Drug Profile
Prostate cancer vaccine Zproxal - Zonagen
Alternative Names: ZproxalLatest Information Update: 15 Sep 2003
Price :
$50
*
At a glance
- Originator Repros Therapeutics
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Prostate cancer
Most Recent Events
- 31 Dec 2002 Discontinued - Clinical-Phase-Unknown for Prostate cancer in Mexico (unspecified route)
- 18 Dec 2000 New profile
- 18 Dec 2000 Investigation in Prostate cancer in Mexico (Unknown route)